Teva Pharmaceutical Industries Stock News

Shares of Teva Pharmaceutical Industries Ltd. TEVA, -2.01% shed 1.2% in premarket trading Wednesday, after the Israel-based generic drug maker reported fourth-quarter profit that topped expectations b

Teva Pharmaceutical (NYSE:TEVA) is scheduled to announce Q4 earnings results on Wednesday, February 9th, before market open.The consensus EPS Estimate is $0.73 (+7.4% Y/Y) and the

Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) has reached a settlement worth $225 million to resolve claims the Company fueled an opioid epidemic in Texas. Texas Attorney General Ken Paxton said Teva agreed to pay $150 million over 15 years … Full story available on Benzinga.com

Teva Pharmaceutical Industries Ltd was facing claims that they fueled an opioid epidemic in Texas by improperly marketing addictive pain medications.

Texas Attorney General Ken Paxton announced an opioid settlement worth $225M with Teva Pharmaceutical <> on Monday.Per the terms, Teva (TEVA) will also provide $75M of…

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and its affiliates, has reached an agreement with the Attorney General (AG) of Texas that settles the state''s and its subdivisions opioid-related claims. Under the terms of the settlement, Teva will pay Texas $150 million over a 15-year time period and will provide the recently launched, lifesaving medicine generic Narcan ® (naloxone hydrochloride nasal spray), valued at $75 million (wholesale acquisition cost) over 10 years. "Expanding access to lifesaving medicines is at the core of Teva''s mission. The Texas Attorney General is taking steps to address the opioid epidemic in the State by negotiating a settlement that includes critical medicines as part of their solution," said Kåre Schultz, Teva''s President and CEO. "While the settlement includes no admission of wrongdoing by Teva or its affiliates, it remains in the best interest of Teva to put these cases behind us and continue to focus on the patients we serve every day." Naloxone is a life-saving medication that can reverse an overdose from opioids. 1 As of December 2021, Teva has made available the first generic version of this critical medicine and has included this product in the Company''s ongoing pursuit of a national or narrower settlement with individual states such as the deal announced today.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and its affiliates, has reached an agreement with

Teva Pharmaceutical Industries Ltd  TEVA has reached a settlement worth $225 million to resolve claims the Company fueled an opioid epidemic in Texas. Get the Inside Access Traders Are Using to Pro

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some bi

Bristol Myers Squibb, General Motors, and Teva Pharmaceutical Industries are three dirt cheap Buffett stocks worth buying right now.

Bristol Myers Squibb, General Motors, and Teva Pharmaceutical Industries are three dirt cheap Buffett stocks worth buying right now.

The U.S. International Trade Commission has opened an investigation into biosimilars of AbbVie Humira (adalimumab) made by Teva Pharmaceutical Industries and Alvotech.

Teva: Competent Management Despite Lawsuits And Debts